# US 2012/0258891 A1 · Diarylsulfide backbone containing photolabile protecting groups

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0258891 A1
- Document ID: US20120258891A1
- Status: Published application
- Kind: A1
- Application number: 13/433,373
- Filed: 2012-03-29
- Published: 2012-10-11
- Earliest claimed: 2011-04-07
- Assignees: Nimblegen Systems Inc.
- Inventors: Klaus-Peter Stengele
- Web page: https://patentgrep.com/patent/US20120258891A1

## CPC

- C07H 19/20: with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07C 319/14: of sulfides
- C07C 323/19: with singly-bound oxygen atoms bound to acyclic carbon atoms of the carbon skeleton
- C07C 323/32: having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
- C07D 207/16: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 213/70: Sulfur atoms
- C07D 231/12: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 235/28: Sulfur atoms
- C07H 1/00: Processes for the preparation of sugar derivatives
- C07H 19/02: sharing nitrogen
- C07H 19/06: Pyrimidine radicals
- C07H 19/10: with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H 19/16: Purine radicals
- C07K 1/04: on carriers {(C07K1/003, C07K1/006 take precedence)}
- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The present disclosure relates to photoactivable protecting groups containing a diarylsulfide chromophore, a method for the synthesis thereof and their use as photoactivable protecting groups using maskless photolithography based array synthesis.

## Claims

### Claim 1

A compound of the formula
wherein Y is S or O, and
A is selected from the group consisting of —CH2—, —CH2—CH2—, —CH(CH3)—, —CH(CH3)—CH2—, and
R1 is an unsubstituted or substituted aryl- or heteroaryl-group, and R3 is H, a methyl group or an ethyl group, and
wherein R2 is H, forms a phosphoramidite, H-phosphonate or phosphate triester, or
wherein R2 is
or wherein R2 is
wherein R4 is H, forms a phosphoramidite, H-phosphonate or phosphate triester, and
wherein R5 is H, OH, a halogen or XR6, wherein X is O or S and R6 is H, an alkyl-group, aryl-group, or OR6 forms a phosphoramidite, phosphodiester, phosphotriester, H-phosphonate or an acetal or silicone moiety, and
wherein B is selected from the group consisting of adenine, cytosine, guanine, thymine, uracil, 2,6-diaminopurine-9-yl, hypoxanthin-9-yl, 5-methylcytosinyl-1-yl, 5-amino-4-imidazolecarboxylic acid-1-yl or 5-amino-4-imidazolecarboxylic acid amide-3-yl, wherein when B is adenine, cytosine or guanine the primary amino group optionally has a protecting group or when B is thymine or uracil at the O4 position is optionally a protecting group, or
wherein R2 is
wherein R7 is a natural amino acid, a non-natural amino acid or an amino acid derivative forming an urethan bond to formula Ib, or
wherein formula IV represents the carboxy function of a natural amino acid, a non-natural amino acid or an amino acid derivative, forming an ester bond to formula Ib.

### Claim 2 (depends on 1)

The compound according to claim 1 wherein R1 is a phenyl-group, a tert-butyl-phenyl group, a 1- or 2-naphthyl-group, a 2-pyridyl-group an aminophenyl-group, an N-alkylaminophenyl-group, an N-Acylaminophenyl-group, a carboxyphenyl-group, a phenylcarboxylic ester or an amide.

### Claim 3 (depends on 1)

The compound according to claim 1 wherein A is —CH(CH3)—CH2—.

### Claim 4 (depends on 1)

The compound according to claim 1 wherein R2 is a phosphoramidite or —P(OCH2CH2CN)(N-iPr2).

### Claim 5 (depends on 1)

The compound according to claim 1 wherein R3 is H or an ethyl group.

### Claim 6 (depends on 1)

The compound according to claim 1 wherein R4 is H and R5 is H.

### Claim 7 (depends on 1)

The compound according to claim 1 wherein B is selected from the group consisting of adenine, cytosine, guanine, thymine or uracil.

### Claim 8 (depends on 1)

The compound according to claim 1 wherein when B is adenine, cytosine or guanine the protecting group is phenoxyacetyl-, 4-tert-butyl-phenoxyacetyl-, 4-isopropyl-phenoxyacetyl- or dimethylformamidino-residues, when B is adenine the protecting group is benzoyl- or p-nitro-phenyl-ethoxy-carbonyl-(p-NPPOC)-residues, when B is guanine the protecting group is isobutyroyl-, p-nitrophenylethyl (p-NPE) or p-NPEOC-residues and when B is cytosine the protecting group is benzoyl-, isobutyryl- or p-NPEOC-residues.

### Claim 9 (depends on 1)

The compound according to claim 1 wherein R7 is a natural amino acid.

### Claim 10 (depends on 1)

A method for preparing a diarylsulfide backbone containing one or more photolabile protecting group(s) according to claim 1 comprising the steps of
a) Provision of p-diethylbenzene as a starting material;
b) Bromination of the phenylring;
c) Nitration of the obtained compound in Nitric- and Sulfuric Acid in the position para- to the Bromine;
d) Purification and crystallization;
e) Hydroxymethylation of the compound at the benzylic position;
f) Conversion of the aromatic bromine group to the arylsulfide using thiophenol;
g) Purification;
h) Conversion of the alcohol to chlorocarbonate; and
i) Reaction of the chlorocarbonate with a nucleoside and reaction of the nucleoside with a phosphitylating agent, or
Reaction of the chlorocarbonate with an amino acid derivative.

### Claim 11 (depends on 10)

The method according to claim 10, characterized in that R1 is a phenyl-group, a tert-butyl-phenyl group, a 1- or 2-naphthyl-group or a 2-pyridyl-group.

### Claim 12 (depends on 10)

The method according to claim 10, characterized in that A is —CH(CH3)—CH2—.

### Claim 13 (depends on 10)

The method according to claim 10, characterized in that R3 is H or an ethyl group.

### Claim 14 (depends on 1)

A method of forming an array through photolithography, said method comprising contacting a substrate having a site activated by exposure to light with a compound of claim 1.

### Claim 15 (depends on 14)

The method of claim 14 wherein R2 is
wherein R7 is a natural amino acid, a non-natural amino acid or an amino acid derivative forming an urethan bond to formula Ib, or
wherein formula IV represents the carboxy function of a natural amino acid, a non-natural amino acid or an amino acid derivative, forming an ester bond to formula Ib.

### Claim 16 (depends on 1, 14)

The method of claim 14 wherein the contacting of the substrate with a compound of claim 1 produces a DNA microarray or a peptide microarray.

### Claim 17 (depends on 16)

The method of claim 16 wherein the method produces a DNA microarray.

### Claim 18 (depends on 16)

The method of claim 16 wherein the method produces a peptide microarray.

### Claim 19 (depends on 14)

The method of claim 14 wherein the substrate and/or the compound is activated by exposure to light between the wavelengths of 374 to 405 nm.
